Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Clopidogrel"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1078
Tytuł:
Dental erosion following clopidogrel administration in a dog: A case-based study.
Autorzy:
Kim SE; Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Veterinary medicine and science [Vet Med Sci] 2024 Mar; Vol. 10 (2), pp. e31384.
Typ publikacji:
Case Reports
MeSH Terms:
Tooth Erosion*/chemically induced
Tooth Erosion*/veterinary
Tooth Diseases*/veterinary
Dog Diseases*/chemically induced
Dog Diseases*/drug therapy
Humans ; Male ; Dogs ; Animals ; Clopidogrel/adverse effects
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Recurrent hypoglycemia induced by clopidogrel: A case report and mini review.
Autorzy:
Du W; Department of Endocrinology and metabolism, Peking University Third Hospital, Beijing, China.
Wang H; Department of Endocrinology and metabolism, Peking University Third Hospital, Beijing, China.
Liu Y; Department of Endocrinology and metabolism, Peking University Third Hospital, Beijing, China.
Hong T; Department of Endocrinology and metabolism, Peking University Third Hospital, Beijing, China.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2024 Mar; Vol. 15 (3), pp. 275-281. Date of Electronic Publication: 2023 Dec 08.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Hypoglycemia*/chemically induced
Hyperinsulinism*
Autoimmune Diseases*
Humans ; Male ; Female ; Clopidogrel ; Hypoglycemic Agents ; Insulin ; Autoantibodies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study.
Autorzy:
Liu X; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Lv X; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Peng Y; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Wang J; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Lei J; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Tang C; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Luo S; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Mai W; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Cai Y; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Fan Q; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Liu C; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China.
Zhang L; The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Meihua East Road, Zhuhai City, Guangdong Province, China. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2024 Mar 01; Vol. 24 (1), pp. 81. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Ischemic Attack, Transient*/drug therapy
Ischemic Attack, Transient*/epidemiology
Ischemic Stroke*/drug therapy
Stroke*/drug therapy
Phenylbutyrates*
Isoindoles*
Humans ; Aspirin ; Clopidogrel/therapeutic use ; Platelet Aggregation Inhibitors/adverse effects ; Prospective Studies ; Hemorrhage/chemically induced ; Drug Therapy, Combination ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial.
Autorzy:
Zhou T; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China.
Gong Y; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China.
Li J; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China.
Wang Y; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China.
Wang X; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China. .
Pokaż więcej
Źródło:
Trials [Trials] 2023 Mar 21; Vol. 24 (1), pp. 209. Date of Electronic Publication: 2023 Mar 21.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Aspirin*/therapeutic use
Clopidogrel*/therapeutic use
Coronary Artery Disease*/complications
Coronary Artery Disease*/diagnosis
Coronary Artery Disease*/therapy
Gastrointestinal Diseases*/etiology
Myocardial Infarction*/complications
Percutaneous Coronary Intervention*/methods
Rivaroxaban*/therapeutic use
Humans ; Drug Therapy, Combination ; Hemorrhage/chemically induced ; Platelet Aggregation Inhibitors/therapeutic use ; Prospective Studies ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Decreased platelet miR-199a-5p level might lead to high on-clopidogrel platelet reactivity in patients with coronary artery disease.
Autorzy:
Hu X; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, Hunan, P.R.China.
Li M; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
Li H; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
Song P; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
Zhang Y; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
Zhou G; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, Hunan, P.R.China.
Tang J; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
Peng L; Department of Cardiovascular Medicine, Xiangya Hospital, Central South university, Changsha, Hunan, P.R.China.
Ma Q; Department of Cardiovascular Medicine, Xiangya Hospital, Central South university, Changsha, Hunan, P.R.China.
Chen X; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
Pokaż więcej
Źródło:
Platelets [Platelets] 2023 Dec; Vol. 34 (1), pp. 2200860.
Typ publikacji:
Journal Article
MeSH Terms:
Coronary Artery Disease*/drug therapy
Coronary Artery Disease*/genetics
Percutaneous Coronary Intervention*
MicroRNAs*/genetics
MicroRNAs*/metabolism
Humans ; Clopidogrel/pharmacology ; Clopidogrel/therapeutic use ; Blood Platelets/metabolism ; Platelet Aggregation Inhibitors/pharmacology ; Platelet Aggregation Inhibitors/therapeutic use ; Cytochrome P-450 CYP2C19/genetics ; Cytochrome P-450 CYP2C19/metabolism ; Ticlopidine/pharmacology ; Ticlopidine/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genetic polymorphism of clopidogrel metabolism related gene CYP2C19 gene in Chinese from Foshan area of Guangdong Province.
Autorzy:
Yuan XW; Department of The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, People's Republic of China.
Yuan SY; Department of The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, People's Republic of China.
Wu GX; Department of The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, People's Republic of China.
Wu ZX; Department of Emergency Medicine, Department of Emergency Medicine, Foshan Hospital of Traditional Chinese Medicin, Foshan, People's Republic of China.
Guan ZY; Department of The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2022 Dec; Vol. 27 (1), pp. 1056-1061.
Typ publikacji:
Journal Article
MeSH Terms:
Clopidogrel*/pharmacology
Clopidogrel*/therapeutic use
Cytochrome P-450 CYP2C19*/genetics
Aryl Hydrocarbon Hydroxylases/genetics ; Aryl Hydrocarbon Hydroxylases/metabolism ; China ; Gene Frequency ; Humans ; Polymorphism, Genetic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Endothelial biomarkers and platelet reactivity on ticagrelor versus clopidogrel in patients after acute coronary syndrome with and without concomitant type 2 diabetes: a preliminary observational study.
Autorzy:
Chyrchel B; Second Department of Cardiology, Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, 2 Jakubowskiego Street, 30-688, Cracow, Poland. .; Department of Cardiology and Cardiovascular Interventions, University Hospital, 2 Jakubowskiego Street, 30-688, Cracow, Poland. .
Kruszelnicka O; Department of Coronary Artery Disease and Heart Failure, Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, 80 Prądnicka Street, 31-202, Cracow, Poland.
Surdacki A; Second Department of Cardiology, Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, 2 Jakubowskiego Street, 30-688, Cracow, Poland.; Department of Cardiology and Cardiovascular Interventions, University Hospital, 2 Jakubowskiego Street, 30-688, Cracow, Poland.
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2022 Nov 17; Vol. 21 (1), pp. 249. Date of Electronic Publication: 2022 Nov 17.
Typ publikacji:
Observational Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Acute Coronary Syndrome*/diagnosis
Acute Coronary Syndrome*/drug therapy
Clopidogrel*/therapeutic use
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Ticagrelor*/therapeutic use
Aged ; Female ; Humans ; Male ; Middle Aged ; Biomarkers ; Platelet Aggregation Inhibitors/therapeutic use ; Stroke Volume ; Ventricular Function, Left
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance.
Autorzy:
Yu R; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.; Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo, People's Republic of China.
Yu Q; Department of Traditional Chinese Internal Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.
Li Z; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.; Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo, People's Republic of China.
Li J; Department of Cardiology, Yuyao People's Hospital of Zhejiang Province, Yuyao, Zhejiang, People's Republic of China.
Yang J; Department of Geriatrics, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.
Hu Y; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.; Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo, People's Republic of China.
Zheng N; Department of Cardiology, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang, People's Republic of China.
Li X; Department of Geriatrics, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.
Song Y; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.
Li J; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.
Chen X; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China. .; Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo, People's Republic of China. .
Du W; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China. .; Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo, People's Republic of China. .
Su J; Department of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China. .; Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo, People's Republic of China. .
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2023 Dec 15; Vol. 15 (1), pp. 194. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Coronary Artery Disease*/drug therapy
Coronary Artery Disease*/genetics
RNA, Long Noncoding*/genetics
Humans ; Clopidogrel/pharmacology ; RNA, Circular/genetics ; Transcriptome ; DNA Methylation ; Adenosine/pharmacology ; RNA, Messenger/genetics ; Jumonji Domain-Containing Histone Demethylases ; Alpha-Ketoglutarate-Dependent Dioxygenase FTO
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clopidogrel-induced non-diabetic hypoglycemia reported from Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a case report.
Autorzy:
Belay KE; Department of Internal Medicine, Endocrinology and Metabolism Unit, Addis Ababa University, Addis Ababa, Ethiopia.
Urge SB; Department of Internal Medicine, Endocrinology and Metabolism Unit, Addis Ababa University, Addis Ababa, Ethiopia.
Birhan YA; Department of Internal Medicine, Cardiology Unit, Addis Ababa University, Addis Ababa, Ethiopia.
Efrem P; Department of Internal Medicine, Endocrinology and Metabolism Unit, Addis Ababa University, Addis Ababa, Ethiopia.
Alemneh TA; Department of Internal Medicine, Endocrinology and Metabolism Unit, Addis Ababa University, Addis Ababa, Ethiopia. .
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Nov 05; Vol. 17 (1), pp. 460. Date of Electronic Publication: 2023 Nov 05.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Acute Coronary Syndrome*
Hypoglycemia*/chemically induced
Humans ; Male ; Adult ; Clopidogrel/adverse effects ; Blood Glucose ; Ethiopia ; Hospitals
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Raman spectra simulation of antiplatelet drug-platelet interaction using DFT.
Autorzy:
Kundalevich A; Immanuel Kant Baltic Federal University, REC 'Fundamental and Applied Photonics', Nanophotonics, Kaliningrad, 236016, Russia. .
Kapitunova A; Immanuel Kant Baltic Federal University, REC 'Fundamental and Applied Photonics', Nanophotonics, Kaliningrad, 236016, Russia.
Berezin K; Institute of Physics, Saratov State University, Saratov, 410012, Russia.
Zyubin A; Immanuel Kant Baltic Federal University, REC 'Fundamental and Applied Photonics', Nanophotonics, Kaliningrad, 236016, Russia.
Moiseeva E; Immanuel Kant Baltic Federal University, Kaliningrad, 236016, Russia.
Rafalskiy V; Immanuel Kant Baltic Federal University, Kaliningrad, 236016, Russia.
Samusev I; Immanuel Kant Baltic Federal University, REC 'Fundamental and Applied Photonics', Nanophotonics, Kaliningrad, 236016, Russia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 16; Vol. 14 (1), pp. 1445. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Journal Article
MeSH Terms:
Platelet Aggregation Inhibitors*/pharmacology
Platelet Aggregation Inhibitors*/metabolism
Aspirin*/pharmacology
Aspirin*/metabolism
Molecular Docking Simulation ; Blood Platelets/metabolism ; Clopidogrel
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Population pharmacokinetic-pharmacodynamic modeling of clopidogrel for dose regimen optimization based on CYP2C19 phenotypes: A proof of concept study.
Autorzy:
Jung YS; Department of Convergence Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
Jin BH; Department of Clinical Pharmacology, Severance Hospital, Yonsei University Health System, Seoul, Korea.
Park MS; Department of Clinical Pharmacology, Severance Hospital, Yonsei University Health System, Seoul, Korea.; Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea.
Kim CO; Department of Clinical Pharmacology, Severance Hospital, Yonsei University Health System, Seoul, Korea.
Chae D; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Jan; Vol. 13 (1), pp. 29-40. Date of Electronic Publication: 2023 Oct 04.
Typ publikacji:
Journal Article
MeSH Terms:
Polymorphism, Genetic*
Ticlopidine*/analogs & derivatives
Humans ; Male ; Clopidogrel ; Cytochrome P-450 CYP2C19/genetics ; Cytochrome P-450 CYP2C19/metabolism ; Genotype ; Phenotype ; Proof of Concept Study ; Prospective Studies ; Clinical Trials, Phase I as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial.
Autorzy:
Mehdizadeh Parizi M; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Golchin Vafa R; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Ahmadi A; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Heydarzade R; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Sadeghi M; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Khademolhossseini A; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Amiri F; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Khoshnood Mansorkhani S; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Tavan A; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Hosseini N; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Montaseri M; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Hosseini SA; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Kojuri J; Professor Kojuri Cardiology Clinic, Shiraz, Iran.; Cardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.; Clinical Education Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Pokaż więcej
Źródło:
Journal of interventional cardiology [J Interv Cardiol] 2023 Dec 26; Vol. 2023, pp. 5544440. Date of Electronic Publication: 2023 Dec 26 (Print Publication: 2023).
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Percutaneous Coronary Intervention*/adverse effects
Acute Coronary Syndrome*/therapy
Humans ; Clopidogrel/adverse effects ; Ticagrelor/therapeutic use ; Ticagrelor/adverse effects ; Platelet Aggregation Inhibitors/adverse effects ; Purinergic P2Y Receptor Antagonists/adverse effects ; Hemorrhage/epidemiology ; Aspirin/therapeutic use ; Dyspnea/etiology ; Stents ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Rare Case of Acute Myocardial Infarction in Pregnancy: Successful Treatment Strategies.
Autorzy:
Zieliński PA; Department of Anatomy Collegium Medicum, Jan Kochanowski University, Kielce, Poland.; General, Oncological and Endocrinological Surgery Clinic, Voivodeship Hospital, Kielce, Poland.
Gawlik Ł; Collegium Medicum, Jan Kochanowski University, Kielce, Poland.
Krupińska J; Department of Internal Medicine, Hospital of the Ministry of the Interior and Administration, Kielce, Poland.; The Doctoral School of Jan Kochanowski University, Kielce, Poland.
Wróbel G; Department of Anatomy Collegium Medicum, Jan Kochanowski University, Kielce, Poland.
Głuchowska M; Department of Internal Medicine, Hospital of the Ministry of the Interior and Administration, Kielce, Poland.
Szeszko A; Department of Internal Medicine, Hospital of the Ministry of the Interior and Administration, Kielce, Poland.
Papros K; Collegium Medicum, Jan Kochanowski University, Kielce, Poland.; Department of Clinical Nephrology, Voivodeship Hospital, Kielce, Poland.
Nowak K; Collegium Medicum, Jan Kochanowski University, Kielce, Poland.
Szeszko Ł; Obstetrics and Gynecology Ward, The Provincial Specialist Hospital, Biała Podlaska, Poland.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2023 Nov 14; Vol. 24, pp. e940790. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hypothyroidism*/complications
Myocardial Infarction*/diagnosis
Myocardial Infarction*/therapy
Myocardial Infarction*/complications
Female ; Humans ; Pregnancy ; Young Adult ; Cesarean Section ; Chest Pain/etiology ; Clopidogrel ; Electrocardiography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Refractory drug-induced systemic small-vessel vasculitis with two varied extracutaneous manifestations: a case report and review of the literature.
Autorzy:
Jovanovic M; Department of Internal Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia. .
Sabovic M; Department of Angiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Oct 27; Vol. 17 (1), pp. 470. Date of Electronic Publication: 2023 Oct 27.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Hematuria*
Vasculitis*/chemically induced
Humans ; Male ; Young Adult ; Aspirin/adverse effects ; Clopidogrel ; Immunoglobulin E ; Naproxen ; Ticagrelor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Secondary right atrial thrombosis in three dogs: Antithrombotics therapy and echocardiographic follow-up.
Autorzy:
Yoshida T; Department of Clinical Veterinary Medicine, Obihiro University of Agriculture and Veterinary Medicine, Hokkaido, Japan.
Uemura A; Department of Clinical Veterinary Medicine, Obihiro University of Agriculture and Veterinary Medicine, Hokkaido, Japan.
Tanaka R; Department of Veterinary Surgery, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Farag A; Department of Veterinary Surgery, Tokyo University of Agriculture and Technology, Tokyo, Japan.; Faculty of Veterinary Medicine, Department of Surgery, Anesthesiology, and Radiology, Zagazig University, Zagazig, Egypt.
Mandour AS; Department of Veterinary Surgery, Tokyo University of Agriculture and Technology, Tokyo, Japan.; Faculty of Veterinary Medicine, Department of Animal Medicine (Internal Medicine), Suez Canal University, Ismailia, Egypt.
Hamabe L; Department of Veterinary Surgery, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Matsumoto K; Department of Clinical Veterinary Medicine, Obihiro University of Agriculture and Veterinary Medicine, Hokkaido, Japan.
Pokaż więcej
Źródło:
Veterinary medicine and science [Vet Med Sci] 2023 Sep; Vol. 9 (5), pp. 1973-1979. Date of Electronic Publication: 2023 Jul 25.
Typ publikacji:
Case Reports
MeSH Terms:
Atrial Fibrillation*/complications
Atrial Fibrillation*/drug therapy
Atrial Fibrillation*/veterinary
Heart Diseases*/diagnostic imaging
Heart Diseases*/drug therapy
Heart Diseases*/veterinary
Thrombosis*/diagnostic imaging
Thrombosis*/drug therapy
Thrombosis*/veterinary
Dog Diseases*/diagnostic imaging
Dog Diseases*/drug therapy
Dogs ; Animals ; Fibrinolytic Agents/therapeutic use ; Rivaroxaban/therapeutic use ; Clopidogrel/therapeutic use ; Follow-Up Studies ; Echocardiography/veterinary ; Heart Atria/diagnostic imaging
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy.
Autorzy:
Nelson TA; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Parker WAE; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Ghukasyan Lakic T; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Westerbergh J; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
James SK; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Siegbahn A; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Becker RC; Division of Cardiovascular Health and Disease, Heart, Lung and Vascular Institute, University of Cincinnati College of Medicine, OH, USA.
Himmelmann A; AstraZeneca Research and Development, Gothenburg, Sweden.
Wallentin L; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Storey RF; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Pokaż więcej
Źródło:
Platelets [Platelets] 2022 Apr 03; Vol. 33 (3), pp. 425-431. Date of Electronic Publication: 2021 Jun 02.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Biomarkers/*metabolism
Clopidogrel/*therapeutic use
Leukocyte Count/*methods
Ticagrelor/*therapeutic use
Clopidogrel/pharmacology ; Double-Blind Method ; Genotype ; Humans ; Risk Factors ; Ticagrelor/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clopidogrel Administration Impairs Post-Stroke Learning and Memory Recovery in Mice.
Autorzy:
Paul M; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW 2308, Australia.; Hunter Medical Research Institute, 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia.; Centre for Rehab Innovations, University of Newcastle, Callaghan, NSW 2308, Australia.
Paul JW; Hunter Medical Research Institute, 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia.; School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW 2308, Australia.
Hinwood M; Hunter Medical Research Institute, 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia.; Centre for Rehab Innovations, University of Newcastle, Callaghan, NSW 2308, Australia.; School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW 2308, Australia.
Hood RJ; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW 2308, Australia.; Hunter Medical Research Institute, 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia.; Discipline of Anatomy and Pathology, School of Biomedicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA 5005, Australia.
Martin K; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW 2308, Australia.; Hunter Medical Research Institute, 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia.
Abdolhoseini M; School of Engineering, College of Engineering, Science and Environment, University of Newcastle, Callaghan, NSW 2308, Australia.
Johnson SJ; Centre for Rehab Innovations, University of Newcastle, Callaghan, NSW 2308, Australia.; School of Engineering, College of Engineering, Science and Environment, University of Newcastle, Callaghan, NSW 2308, Australia.
Pollack M; Hunter Medical Research Institute, 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia.; Centre for Rehab Innovations, University of Newcastle, Callaghan, NSW 2308, Australia.; School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW 2308, Australia.
Nilsson M; Hunter Medical Research Institute, 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia.; Centre for Rehab Innovations, University of Newcastle, Callaghan, NSW 2308, Australia.; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.; LKC School of Medicine, Nanyang Technological University, Singapore 639798, Singapore.
Walker FR; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW 2308, Australia.; Hunter Medical Research Institute, 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia.; Centre for Rehab Innovations, University of Newcastle, Callaghan, NSW 2308, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 20; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 20.
Typ publikacji:
Journal Article
MeSH Terms:
Stroke*/complications
Stroke*/drug therapy
Stroke*/metabolism
Male ; Humans ; Clopidogrel/pharmacology ; Clopidogrel/therapeutic use ; Platelet Aggregation Inhibitors/pharmacology ; Platelet Aggregation Inhibitors/therapeutic use ; Cognition ; Body Weight
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The safety and effectiveness of clopidogrel versus aspirin in Kawasaki disease with mild-to-moderate liver injury.
Autorzy:
Gao L; Department of Cardiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Hangzhou, 310052, People's Republic of China.
Wang W; Department of Cardiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Hangzhou, 310052, People's Republic of China.
Wang H; Department of Cardiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Hangzhou, 310052, People's Republic of China.
Xu Z; Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
Zhou S; Department of Cardiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Hangzhou, 310052, People's Republic of China.
Geng Z; Department of Cardiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Hangzhou, 310052, People's Republic of China.
Fu S; Department of Cardiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Hangzhou, 310052, People's Republic of China.
Xie C; Department of Cardiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Hangzhou, 310052, People's Republic of China.
Zhang Y; Department of Cardiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Hangzhou, 310052, People's Republic of China.
Wang Y; Department of Cardiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Hangzhou, 310052, People's Republic of China. .
Gong F; Department of Cardiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Hangzhou, 310052, People's Republic of China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Oct 26; Vol. 13 (1), pp. 18324. Date of Electronic Publication: 2023 Oct 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Aspirin*/adverse effects
Mucocutaneous Lymph Node Syndrome*/complications
Mucocutaneous Lymph Node Syndrome*/drug therapy
Child ; Humans ; Clopidogrel/adverse effects ; Platelet Aggregation Inhibitors/adverse effects ; Retrospective Studies ; Alanine Transaminase ; Treatment Outcome ; Drug Therapy, Combination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prescription patterns of P2Y12 inhibitors following revascularization in the United States: 2013-2018.
Autorzy:
Kumar A; Department of Pharmacy Practice and Administrative Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA.
Lutsey PL; Division of Epidemiology and Community Health, University of Minnesota, School of Public Health, Minneapolis, Minnesota, USA.
St Peter WL; Department of Pharmaceutical Care and Health Systems, University of Minnesota, College of Pharmacy, Minneapolis, Minnesota, USA.
Schommer JC; Department of Pharmaceutical Care and Health Systems, University of Minnesota, College of Pharmacy, Minneapolis, Minnesota, USA.
Van't Hof JR; Cardiovascular Division, Lillehei Heart Institute, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Rajpurohit A; Department of Pharmaceutical Care and Health Systems, University of Minnesota, College of Pharmacy, Minneapolis, Minnesota, USA.
Farley JF; Department of Pharmaceutical Care and Health Systems, University of Minnesota, College of Pharmacy, Minneapolis, Minnesota, USA.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2023 Oct; Vol. 16 (10), pp. 1886-1897. Date of Electronic Publication: 2023 Aug 03.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Coronary Artery Disease*/drug therapy
Acute Coronary Syndrome*/chemically induced
Acute Coronary Syndrome*/drug therapy
Humans ; United States/epidemiology ; Aged ; Clopidogrel/adverse effects ; Ticagrelor/adverse effects ; Platelet Aggregation Inhibitors/adverse effects ; Purinergic P2Y Receptor Antagonists/adverse effects ; Prescriptions ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CYP2C19 loss-of-function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel.
Autorzy:
Ramste M; Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Ritvos M; Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Häyrynen S; Veracell Oy, Tampere, Finland.
Kiiski JI; Department of Clinical Pharmacology and Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Niemi M; Department of Clinical Pharmacology and Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.
Sinisalo J; Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2023 Oct; Vol. 16 (10), pp. 2010-2020. Date of Electronic Publication: 2023 Aug 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Platelet Aggregation Inhibitors*/adverse effects
Stroke*
Humans ; Clopidogrel/adverse effects ; Alleles ; Esomeprazole/adverse effects ; Omeprazole/adverse effects ; Cytochrome P-450 CYP2C19/genetics ; Prospective Studies ; Genotype ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 1078

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies